Yeah almost back to where the last run started. Shame this
Top 10 Most Recent News Articles
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst
A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...
Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle
Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...
Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis
A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...
Continue Reading
Human Frontier Mission Puts AI Research on Display
A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...
Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos
A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...
Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power
A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...
Continue ReadingTop 5 Most Recently Viewed Articles
Embrace Pet Insurance Breaks Records in Volunteerism and Giving
Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...
Continue Reading
Sony's Innovative OLED Microdisplay Sets New Industry Standards
Exploring Sony's Innovative OLED Technology Sony Semiconductor Solutions Corporation is about to change the landscape of augmented reality (AR) with the introduction of its groundbreaking ECX350F. This 0.44-type Full HD OLED Microdisplay is remarkable for its unique features, including the smallest pixel size in the industry and outstanding brightness. This innovation...
Continue Reading
Bascom Palmer Eye Institute Claims Top Spot in Medical Rankings
Bascom Palmer Eye Institute's Unrivaled Recognition in 2025 For an impressive 24th consecutive year, Bascom Palmer Eye Institute has been honored as the premier ophthalmology hospital in the United States. This prestigious recognition, detailed in the 2025 U.S. News & World Report "Best Hospitals" rankings, underscores the institute's unwavering commitment to providing...
Continue Reading
Insights on Unusual Options Activity for Alphabet Inc.
Unusual Options Activity Analysis for Alphabet Inc. Recent trends indicate that prominent financial players are adopting a bearish stance on Alphabet Inc. Our thorough analysis of options history for Alphabet (GOOGL) highlights 20 unusual trades, emphasizing a notable shift in market sentiment. Understanding Trader Sentiment Upon delving into the trade specifics, our...
Continue Reading
A Critical Juncture for uniQure Amidst Regulatory Challenges
uniQure's Recent FDA Feedback The U.S. Food and Drug Administration (FDA) recently provided important insights to uniQure N.V. (NASDAQ: QURE) about its proposed gene therapy for Huntington’s disease. This feedback has led to a noticeable drop in the company’s stock price, reflecting heightened investor concern. Understanding AMT-130 AMT-130 is uniQure’s...
Continue Reading